GynecologyNews.net

Gynecology Xagena

Xagena Mappa
Medical Meeting
Reumabase.it
Mediexplorer.it

Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the ...


A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-bloc ...


A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. Bazedoxifene ( Conbriza ), a drug for the treat ...


The taller a postmenopausal woman is, the greater her risk for developing cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Associat ...


The EMA ( European Medicines Agency ) has been asked by France to review third- and fourth-generation combined oral contraceptives to determine whether there is a need to restrict the use of these med ...


The French medicines agency has announced its plan to suspend the marketing authorisation for Diane 35 ( Cyproterone acetate 2 mg / Ethinylestradiol 35 micrograms ) and its generics for acne treatment ...


A randomized, non-inferiority trial conducted by the French National Cancer Institute ( INCa ) has compared a shorter Trastuzumab ( Herceptin ) exposure of 6 months versus the standard 12 months treat ...


Halaven ( Eribulin mesylate ), a non-taxane, microtubule dynamics inhibitor with a novel mechanism of action, belongs to a class of antineoplastic agents, the halichondrins, which are natural products ...


One year of adjuvant treatment with the targeted drug Trastuzumab ( Herceptin ) is as good as two years of treatment, for women with HER2-positive early breast cancer who have already received initial ...


The FDA ( Food and Drug Administration ) has granted 510(k) clearance for marketing and use of a combination of blood tests for proteins HE4 and CA125 with the Risk of Ovarian Malignancy Algorithm ( R ...


Acetylsalicylic acid ( Aspirin; ASA ) and low-molecular-weight Heparin are prescribed for women with unexplained recurrent miscarriage, with the goal of improving the rate of live births, but limited ...


Lasofoxifene ( Fablyn ) statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density.Lasofoxifene is a SERM, or ...


Results of a new Women's Health Initiative ( WHI ) report has shown that hormone therapy is associated with an increased risk of death from breast cancer, as well as an increased risk of developing in ...


A new analysis has found that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization. Published in Cancer, a jour ...


A team of researchers have found that patients with a very early form of breast cancer ( ductal carcinoma in situ or DCIS ) who have higher mammographic density may be at increased risk for subsequent ...